Thermo Fisher Scientific: Patient Investors Will Be Rewarded $TMO
Thermo Fisher Scientific (NYSE:TMO) is a leader in the scientific equipment space specifically with a focus on healthcare. TMO is organized in four segments (1) Life Sciences Solutions, (2) Specialty Diagnostics, (3) Analytical Instruments, and (4) Laboratory Products and BioPharma Services.
![TMO Segments](https://static.seekingalpha.com/uploads/2022/4/13/7257631-16498554319895473.png)
TMO Segments (TMO Investor Relations)
Their hands are in effectively every part of the R&D process for the global healthcare marketplace. If you're bullish on healthcare R&D spending which I am as diagnostics and new therapies become more and more specialized, then TMO is poised to benefit on that spending.
![TMO Revenue Profile](https://static.seekingalpha.com/uploads/2022/4/13/7257631-1649855573383715.png)
TMO Revenue Profile (TMO Investor Relations)
TMO's revenues come from just about every sector of the healthcare R&D process. TMO also generates plenty of recurring revenues in the form of both consumables for their various equipment as well as servicing and maintenance.
Comments
Post a Comment